Inflammatory Markers Clinical Trial

Enter your name and email below to receive the results


CFH, Ltd. is a vertically integrated BioScience company committed to making therapeutic hemp-based products, that enhance people’s health through science and research and development. Controlling the entire supply chain from the genetic development through to the finished product insures traceability, consistency and efficacy.   

Emerging research continues to build in support of the many health benefits and applications of CBD. Today, there are a few leading companies making the commitment to provide clinical evidence documenting the effectiveness of these applications and providing educational data to health care providers, researchers and consumers.

CFH, Ltd. is one of the leading companies. Inflammation is a significant driver for disease, and this Inflammatory Marker trial provides evidence of the effectiveness of Full Spectrum Hemp Flower-derived cannabinoids and terpenes in reducing inflammation.  

Inflammatory Markers Clinical Trial